Prnewswire Hikma Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire hikma pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Hikma Pharmaceuticals Today - Breaking & Trending Today

Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today welcomed Dr. Rahul Gupta, Director of the White House Office. ....

United Kingdom , United States , United Arab Emirates , David Belian , Steve Weiss , Brian Hoffmann , Kenneth Stammen , Rahul Gupta , Kelsey Caitlin Bates , Office Of National Drug Control , Hikma Community Health , Prnewswire Hikma Pharmaceuticals , Community Strategy , Us Communications , Hikma Pharmaceuticals United States Inc , Hikma Specialty United States Inc , Public Affairs , Continues Hikma , National Drug Control Policy , White House Office , Unity Agenda , President Biden , Black Community Strategy Director , Regional Coordinator , Harm Reduction , Hikma Community ,

Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that on the two-year anniversary of its launch, it has. ....

United Arab Emirates , United Kingdom , United States , City Of , David Belian , Brian Hoffmann , Susan Ringdal , Steve Weiss , Hikma Pharmaceuticals United States Inc , Emergent Operations Ireland , Hikma Community Health , Public Affairs , Naloxone Network Buyers Club , Hikma Pharmaceuticals , Us Communications , Pay Assistance Program , Washington Post , Community Programs , Prnewswire Hikma Pharmaceuticals , Hikma Specialty United States Inc , Global Affairs , White House Office Of National Drug Control , White House Office , National Drug Control Policy , Opioid Safety , For The People ,

Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in. ....

United States , United Kingdom , City Of , United Arab Emirates , Steve Weiss , Susan Ringdal , David Belian , Us Communications , Regional Poison Control Center , Hikma Pharmaceuticals United States Inc , Public Affairs , Hikma Pharmaceuticals , Prnewswire Hikma Pharmaceuticals , Global Affairs , Dobutamine Injection , Riad Mishlawi , Strategic Planning , Middle East , North Africa , Safety Information , Heart Rate , Blood Pressure , Following Acute Myocardial Infarction , Ventricular Ectopic Activity , Intravenous Infusion , Uncommon Effects ,

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark. ....

United States , United Arab Emirates , United Kingdom , City Of , Steve Weiss , Leonard Bielory , Susan Ringdal , David Belian , Udaykumar Murthy , Brian Hoffmann , Brendan Ogrady , Global Affairs , Hikma Pharmaceuticals United States Inc , Public Affairs , Drug Administration , Hackensack Meridian School Of Medicine , Linkedin Glenmark Pharmaceuticals , Glenmark Pharmaceuticals , National Institute For Health , Us Communications , Prnewswire Hikma Pharmaceuticals , Corporate Communications , Biosimilars Companies , Glenmark Pharmaceuticals Ltd , Hikma Pharmaceuticals , Hackensack Meridian School ,

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

/PRNewswire/ Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire. ....

United Arab Emirates , United States , United Kingdom , City Of , Prnewswire Hikma Pharmaceuticals , Opiant Pharmaceuticals , Hikma Pharmaceuticals , Nasal Nalmefene , Middle East , North Africa , Hikma Pharmaceuticals Plc ,